Leukemia Research
Volume 24, Issue 4 , Pages 307-316, April 2000

All trans retinoic acid induces apoptosis in acute promyelocytic NB4 cells when combined with isoquinolinediol, a poly(ADP-ribose) polymerase inhibitor

  • Donna M. Berry

      Affiliations

    • Arthur and Sonia LaBatt Brain Tumor Research Center, Hospital for Sick Children, 555 University Avenue, Toronto, Ont., Canada M5G 1X8
  • ,
  • Kathleen Williams

      Affiliations

    • Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ont., Canada, N1G 2W1
  • ,
  • Kelly A. Meckling-Gill

      Affiliations

    • Department of Human Biology and Nutritional Sciences, University of Guelph, Guelph, Ont., Canada, N1G 2W1
    • Corresponding Author InformationCorresponding author. Tel.: +1-519-824-4120, ext 3742; fax: +1-519-763-5902

Received 1 June 1999; accepted 13 October 1999.

Abstract 

NB4 cells, a model of acute promyelocytic leukemia have been shown to undergo granulocytic differentiation in response to all trans retinoic acid (ATRA), or monocytic differentiation in response to 1α,25 dihydroxyvitamin D3 (1,25 D3) and phorbol ester. We have shown previously that the expression of poly(ADP-ribose) polymerase (PARP) is dramatically increased during monocytic differentiation and completely down-regulated during neutrophilic differentiation. Here we show that NB4 cells simultaneously treated with ATRA and isoquinolinediol (Iso-Q), a specific PARP inhibitor, fail to differentiate into neutrophils. Nitroblue tetrazolium (NBT) dye reduction was inhibited by 48% and neutrophil formation was reduced by 75%. NB4 cells treated with ATRA and Iso-Q instead showed features of apoptosis including nuclear condensation, DNA fragmentation, and PARP cleavage yielding a 85 kDa fragment. NB4 cells treated with ATRA in combination with 1,25 D3, a monocytic differentiation inducer, while continuing to reduce NBT also failed to mature into neutrophils or monocytes and again showed features of apoptosis. Down-regulation of Bcl-2 protein expression was evident in NB4 cells treated with ATRA and ATRA in combination with Iso-Q or 1,25 D3, but not in cells treated with a classic chemotherapeutic agent, arabinosycytosine, suggesting that Bcl-2 down-regulation is neither necessary, nor specific for apoptosis in this model.

Keywords: Apoptosis, All-trans retinoic acid, 1α,25 dihydroxyvitamin D3, Differentiation, NB4, Poly(ADP-ribose) polymerase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(99)00188-5

Leukemia Research
Volume 24, Issue 4 , Pages 307-316, April 2000